Sime Darby Oils, UKM plan liver treatment trials using palm oil extract

Sime Darby Oils MD Mohd Haris Mohd Arshad said: "The importance of developing partnerships with institutions such as the UKM is that it allows for both the development and practical implementation of our findings."

KUALA LUMPUR: Sime Darby Oils (SDO) and Universiti Kebangsaan Malaysia (UKM) will carry out clinical trials to find out if the palm oil derived Tocotrienols can be used in treating non-alcoholic fatty liver disease (NAFLD).

In a joint statement issued on Tuesday, they said this is the world’s first comprehensive clinical trial whether Tocotrienols, an antioxidant in the vitamin E family, could be used in NAFLD treatment.

Limited time offer:
Just RM5 per month.

Monthly Plan


Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan


Billed as RM148.00/year

1 month

Free Trial

For new subscribers only

Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Wall St set for lower open as some big bank earnings disappoint
Citi profit drops as costs rise for employee severance, deposit insurance
Asia spot LNG at 3-month peak on steady demand, supply disruption
Global spotlight on Malaysia as it emerges as semiconductor powerhouse
Ringgit ends easier versus US dollar on higher-than-expected US inflation data
Nextgreen IOI Pulp inks MoU with Xiamen C&D for pulp production facility
Mosti to launch Single Window Initiative to strengthen Malaysia's startup ecosystem
China strengthens company delisting rules to improve markets
Gamuda Land collaborates with Kiddypedia for Discovery Centres at Gamuda Gardens, twentyfive7
FBM KLCI ends lower in line with regional peers

Others Also Read